Innovid (CTV) Stock Forecast, Price Target & Predictions
CTV Stock Forecast
Innovid stock forecast is as follows: an average price target of $2.50 (represents a 38.12% upside from CTV’s last price of $1.81) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
CTV Price Target
CTV Analyst Ratings
Innovid Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 23, 2024 | Matthew Cost | Morgan Stanley | $2.50 | $2.03 | 23.15% | 38.12% |
Apr 16, 2024 | Matthew Cost | Morgan Stanley | $2.10 | $2.23 | -5.83% | 16.02% |
Innovid Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 2 |
Avg Price Target | - | $2.50 | $2.30 |
Last Closing Price | $1.81 | $1.81 | $1.81 |
Upside/Downside | -100.00% | 38.12% | 27.07% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 06, 2024 | Needham | Market Outperform | Market Outperform | Hold |
Jul 23, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Jul 12, 2024 | Needham | Market Outperform | Market Outperform | Hold |
Jun 04, 2024 | Needham | Market Outperform | Market Outperform | Hold |
Apr 16, 2024 | Needham | Market Outperform | Market Outperform | Hold |
Apr 16, 2024 | Morgan Stanley | Underperform | Underperform | Hold |
Apr 16, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Feb 16, 2024 | Wedbush | Outperform | Outperform | Hold |
May 11, 2023 | Oppenheimer | Outperform | Outperform | Hold |
Feb 25, 2022 | Needham | Buy | Buy | Hold |
Innovid Financial Forecast
Innovid Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $38.62M | $36.23M | - | $30.48M | $33.70M | $34.47M | $33.09M | $25.86M | $25.97M |
Avg Forecast | $50.30M | $47.40M | $43.50M | $40.40M | $43.80M | $40.80M | $38.50M | $35.15M | $36.20M | $35.47M | $32.00M | $29.53M | $35.47M | $34.47M | $33.50M | $21.27M | $27.05M |
High Forecast | $50.30M | $47.40M | $43.50M | $40.40M | $43.80M | $40.80M | $38.50M | $35.15M | $36.20M | $35.47M | $32.00M | $29.53M | $35.47M | $34.47M | $33.50M | $21.27M | $27.05M |
Low Forecast | $50.30M | $47.40M | $43.50M | $40.40M | $43.80M | $40.80M | $38.50M | $35.15M | $36.20M | $35.47M | $32.00M | $29.53M | $35.47M | $34.47M | $33.50M | $21.27M | $27.05M |
# Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 |
Surprise % | - | - | - | - | - | - | - | - | 1.07% | 1.02% | - | 1.03% | 0.95% | 1.00% | 0.99% | 1.22% | 0.96% |
Innovid EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 |
EBITDA | - | - | - | - | - | - | - | - | $1.64M | $5.11M | - | $-6.18M | $-2.08M | $-4.15M | $-8.25M | $-9.12M | $-6.53M |
Avg Forecast | $-3.57M | $-3.36M | $-3.09M | $-2.87M | $-3.11M | $-2.90M | $-2.73M | $-2.49M | $-2.57M | $-2.52M | $-2.27M | $-2.10M | $-2.52M | $-2.45M | $-2.38M | $-3.60M | $-334.89M |
High Forecast | $-3.57M | $-3.36M | $-3.09M | $-2.87M | $-3.11M | $-2.90M | $-2.73M | $-2.49M | $-2.57M | $-2.52M | $-2.27M | $-2.10M | $-2.52M | $-2.45M | $-2.38M | $-2.88M | $-267.91M |
Low Forecast | $-3.57M | $-3.36M | $-3.09M | $-2.87M | $-3.11M | $-2.90M | $-2.73M | $-2.49M | $-2.57M | $-2.52M | $-2.27M | $-2.10M | $-2.52M | $-2.45M | $-2.38M | $-4.32M | $-401.86M |
Surprise % | - | - | - | - | - | - | - | - | -0.64% | -2.03% | - | 2.95% | 0.83% | 1.70% | 3.47% | 2.53% | 0.02% |
Innovid Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 |
Net Income | - | - | - | - | - | - | - | - | $-1.66M | $-2.73M | - | $-8.56M | $-3.43M | $-11.83M | $4.30M | $-7.45M | $-7.62M |
Avg Forecast | $4.34M | $1.45M | $-4.34M | $-723.86K | $965.20K | $-482.53K | $-1.93M | $-2.90M | $-965.20K | $-1.93M | $-4.34M | $-6.76M | $-2.90M | $-6.76M | $-5.79M | $-5.96M | $-390.80M |
High Forecast | $4.34M | $1.45M | $-4.34M | $-723.86K | $965.20K | $-482.53K | $-1.93M | $-2.90M | $-965.20K | $-1.93M | $-4.34M | $-6.76M | $-2.90M | $-6.76M | $-5.79M | $-4.77M | $-312.64M |
Low Forecast | $4.34M | $1.45M | $-4.34M | $-723.86K | $965.20K | $-482.53K | $-1.93M | $-2.90M | $-965.20K | $-1.93M | $-4.34M | $-6.76M | $-2.90M | $-6.76M | $-5.79M | $-7.15M | $-468.96M |
Surprise % | - | - | - | - | - | - | - | - | 1.72% | 1.41% | - | 1.27% | 1.18% | 1.75% | -0.74% | 1.25% | 0.02% |
Innovid SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 |
SG&A | - | - | - | - | - | - | - | - | $22.06M | $20.93M | - | $21.29M | $20.56M | $22.77M | $24.27M | $21.99M | $19.61M |
Avg Forecast | $31.18M | $29.38M | $26.96M | $25.04M | $27.15M | $25.29M | $23.86M | $21.79M | $22.44M | $21.98M | $19.84M | $18.31M | $21.98M | $21.36M | $20.77M | $17.59M | $16.77M |
High Forecast | $31.18M | $29.38M | $26.96M | $25.04M | $27.15M | $25.29M | $23.86M | $21.79M | $22.44M | $21.98M | $19.84M | $18.31M | $21.98M | $21.36M | $20.77M | $21.11M | $16.77M |
Low Forecast | $31.18M | $29.38M | $26.96M | $25.04M | $27.15M | $25.29M | $23.86M | $21.79M | $22.44M | $21.98M | $19.84M | $18.31M | $21.98M | $21.36M | $20.77M | $14.07M | $16.77M |
Surprise % | - | - | - | - | - | - | - | - | 0.98% | 0.95% | - | 1.16% | 0.94% | 1.07% | 1.17% | 1.25% | 1.17% |
Innovid EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 |
EPS | - | - | - | - | - | - | - | - | $-0.01 | $-0.02 | - | $-0.06 | $-0.03 | $-0.09 | $0.03 | $-0.06 | $-0.14 |
Avg Forecast | $0.03 | $0.01 | $-0.03 | $-0.01 | $0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.01 | $-0.01 | $-0.03 | $-0.05 | $-0.02 | $-0.05 | $-0.04 | $-0.05 | $-0.01 |
High Forecast | $0.03 | $0.01 | $-0.03 | $-0.01 | $0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.01 | $-0.01 | $-0.03 | $-0.05 | $-0.02 | $-0.05 | $-0.04 | $-0.05 | $-0.01 |
Low Forecast | $0.03 | $0.01 | $-0.03 | $-0.01 | $0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.01 | $-0.01 | $-0.03 | $-0.05 | $-0.02 | $-0.05 | $-0.04 | $-0.05 | $-0.01 |
Surprise % | - | - | - | - | - | - | - | - | 1.77% | 1.50% | - | 1.35% | 1.28% | 1.91% | -0.75% | 1.20% | 10.50% |
CTV Forecast FAQ
Is Innovid a good buy?
Yes, according to 4 Wall Street analysts, Innovid (CTV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of CTV's total ratings.
What is CTV's price target?
Innovid (CTV) average price target is $2.5 with a range of $2.5 to $2.5, implying a 38.12% from its last price of $1.81. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Innovid stock go up soon?
According to Wall Street analysts' prediction for CTV stock, the company can go up by 38.12% (from the last price of $1.81 to the average price target of $2.5), up by 38.12% based on the highest stock price target, and up by 38.12% based on the lowest stock price target.
Can Innovid stock reach $3?
CTV's average twelve months analyst stock price target of $2.5 does not support the claim that Innovid can reach $3 in the near future.
What are Innovid's analysts' financial forecasts?
Innovid's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $158.25M (high $158.25M, low $158.25M), average EBITDA is $-11.231M (high $-11.231M, low $-11.231M), average net income is $-4.343M (high $-4.343M, low $-4.343M), average SG&A $98.09M (high $98.09M, low $98.09M), and average EPS is $-0.03 (high $-0.03, low $-0.03). CTV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $181.6M (high $181.6M, low $181.6M), average EBITDA is $-12.888M (high $-12.888M, low $-12.888M), average net income is $723.86K (high $723.86K, low $723.86K), average SG&A $112.57M (high $112.57M, low $112.57M), and average EPS is $0.005 (high $0.005, low $0.005).
Did the CTV's actual financial results beat the analysts' financial forecasts?
Based on Innovid's last annual report (Dec 2023), the company's revenue was $139.88M, beating the average analysts forecast of $133.2M by 5.02%. Apple's EBITDA was $-5.458M, missing the average prediction of $-9.453M by -42.26%. The company's net income was $-31.911M, beating the average estimation of $-13.995M by 128.02%. Apple's SG&A was $84.66M, beating the average forecast of $82.57M by 2.53%. Lastly, the company's EPS was $-0.23, beating the average prediction of $-0.0967 by 137.93%. In terms of the last quarterly report (Dec 2023), Innovid's revenue was $38.62M, beating the average analysts' forecast of $36.2M by 6.68%. The company's EBITDA was $1.64M, missing the average prediction of $-2.569M by -163.80%. Innovid's net income was $-1.658M, beating the average estimation of $-965K by 71.78%. The company's SG&A was $22.06M, missing the average forecast of $22.44M by -1.70%. Lastly, the company's EPS was $-0.0118, beating the average prediction of $-0.00667 by 76.99%